This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Castlight (CSLT) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Castlight (CSLT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why Castlight Health (CSLT) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Castlight Health (CSLT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Castlight Health's (CSLT) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Castlight Health, Inc. (CSLT).
Calix (CALX) Unveils GigaSpire BLAST u6x, Spurs Network Setup
by Zacks Equity Research
Calix (CALX) unveils GigaSpire BLAST u6x, the latest addition to the GigaSpire BLAST portfolio, to enhance the Wi-Fi 6 experience with a streamlined network infrastructure.
Veeva (VEEV) Partners With Impel, Boosts Cloud-Based Offerings (Revised)
by Zacks Equity Research
Veeva (VEEV) collaborates with Impel to accelerate the pre-launch planning and digital-first commercial execution for migraine treatment.
Castlight (CSLT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Castlight (CSLT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Veeva (VEEV) Partners With Impel, Boosts Cloud-Based Offerings
by Zacks Equity Research
Veeva (VEEV) collaborates with Impel to accelerate the pre-launch planning and digital-first commercial execution for migraine treatment.
Castlight Health (CSLT) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Castlight (CSLT) delivered earnings and revenue surprises of 133.33% and 17.32%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Castlight Health (CSLT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Castlight (CSLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Castlight Health (CSLT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Castlight (CSLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Castlight Health (CSLT) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Castlight (CSLT) delivered earnings and revenue surprises of 125.00% and 16.78%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Castlight Health (CSLT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Castlight (CSLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Castlight Health (CSLT) in Focus: Stock Moves 7.3% Higher
by Zacks Equity Research
Castlight Health (CSLT) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
All You Need to Know About Castlight (CSLT) Rating Upgrade to Buy
by Zacks Equity Research
Castlight (CSLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Castlight Health (CSLT) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Castlight (CSLT) delivered earnings and revenue surprises of -300.00% and 0.70%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Castlight Health (CSLT) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Castlight (CSLT) delivered earnings and revenue surprises of -100.00% and -2.02%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Castlight Health (CSLT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Castlight (CSLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Castlight Health (CSLT) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
Castlight (CSLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IPG Photonics (IPGP) Q1 Earnings Lag, Revenues Top Estimates
by Zacks Equity Research
Lower demand from China and Europe, owing to macroeconomic headwinds, adversely impacted IPG Photonics' (IPGP) first-quarter results.
Western Digital (WDC) Earnings & Revenues Miss Estimates in Q3
by Zacks Equity Research
Western Digital's (WDC) third-quarter results adversely impacted by softness in NAND flash pricing trends and sluggishness in end markets.
Castlight Health (CSLT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Castlight (CSLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Skyworks Deploys Mini Circulators, Boosts 5G Wireless Network
by Zacks Equity Research
Skyworks' (SWKS) growing clout in the connectivity solutions and 5G markets is a positive.
Western Digital Unveils microSD Card for Surveillance Cameras
by Zacks Equity Research
The ongoing expansion of the Western Digital's product portfolio will bode well for the company's top line.
Castlight (CSLT) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Castlight (CSLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for April 11th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday